Next report date
Report period
Q1 2024
EPS estimate
−0.29USD
Revenue estimate
24.35 MUSD
−1.49USD
−63.32 MUSD
96.63 MUSD
21.31 M
About Akoya BioSciences, Inc.
Sector
Industry
CEO
Brian McKelligon
Website
Headquarters
Marlborough
Employees (FY)
330
Founded
2015
FIGI
BBG00JX4LRV6
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AKYA is 3.81 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Akoya BioSciences, Inc. stocks are traded under the ticker AKYA.
Akoya BioSciences, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
AKYA stock is 2.67% volatile and has beta coefficient of 4.19. Check out the list of the most volatile stocks — is Akoya BioSciences, Inc. there?
AKYA earnings for the last quarter are −0.26 USD per share, whereas the estimation was −0.36 USD resulting in a 27.19% surprise. The estimated earnings for the next quarter are −0.27 USD per share. See more details about Akoya BioSciences, Inc. earnings.
Akoya BioSciences, Inc. revenue for the last quarter amounts to 25.22 M USD despite the estimated figure of 24.51 M USD. In the next quarter revenue is expected to reach 26.14 M USD.
Yes, you can track Akoya BioSciences, Inc. financials in yearly and quarterly reports right on TradingView.
AKYA stock has fallen by 2.56% compared to the previous week, the month change is a 22.40% fall, over the last year Akoya BioSciences, Inc. has showed a 43.13% decrease.
AKYA net income for the last quarter is −10.80 M USD, while the quarter before that showed −12.92 M USD of net income which accounts for 16.37% change. Track more Akoya BioSciences, Inc. financial stats to get the full picture.
Today Akoya BioSciences, Inc. has the market capitalization of 187.23 M, it has decreased by 2.01% over the last week.
No, AKYA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AKYA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Akoya BioSciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 330.00 employees. See our rating of the largest employees — is Akoya BioSciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Akoya BioSciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Akoya BioSciences, Inc. stock shows the sell signal. See more of Akoya BioSciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Akoya BioSciences, Inc. future price: according to them, AKYA price has a max estimate of 11.00 USD and a min estimate of 7.00 USD. Read a more detailed Akoya BioSciences, Inc. forecast: see what analysts think of Akoya BioSciences, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Akoya BioSciences, Inc. EBITDA is −47.14 M USD, and current EBITDA margin is −48.78%. See more stats in Akoya BioSciences, Inc. financial statements.